5-Ethynyl-1-methyl-1H-imidazole

Catalog No.: 
ACPTVF150
CAS No.: 
71759-92-7
Molecular Formula: 
C6H6N2
Molecular Weight: 
106.13
5-Ethynyl-1-methyl-1H-imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$54.00In stockInquiry
250mg95%$77.00In stockInquiry
1g95%$212.00In stockInquiry
5g95%$1060.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Ethynyl-1-methyl-1H-imidazole
IUPAC Name5-ethynyl-1-methyl-1H-imidazole
MDL No.MFCD04974089
Molecular FormulaC6H6N2
Molecular Weight106.13
SMILESCN1C=NC=C1C#C
InChI KeyJFOSWQQRTHDTGG-UHFFFAOYSA-N
SynonymDTXSID90391550 | JFOSWQQRTHDTGG-UHFFFAOYSA-N | 5-ethynyl-1-methyl-1-H-imidazole | 5-Ethynyl-1-methyl-1H-imidazole | SCHEMBL378803 | EN300-787633 | J-517480 | D81734 | CS-0261504 | AKOS015916325 | 1H-Imidazole,5-ethynyl-1-methyl- | MFCD04974089 | 5-Ethynyl
CAS No.71759-92-7
PubChem CID3333106

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPTVF150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACURKE386 route compound structure diagram
    ACURKE38671759-88-1In Stock
  4. Then
  5. ACPTVF150 route product structure diagram
    ACPTVF15071759-92-7In Stock
Inquiry

2. ACPTVF150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPTVF150 route product structure diagram
    ACPTVF15071759-92-7In Stock
Inquiry

3. ACPTVF150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPTVF150 route product structure diagram
    ACPTVF15071759-92-7In Stock
Inquiry

Comments (0)